关于 Tizanidine Hydrochloride API
治疗类别 中枢神经系统 (CNS)

CAS 编号
64461-82-1
API 技术
合成
剂型
胶囊/片剂
Dr Reddy's 开发状态
可用的
可用的法规申报文件
USDMF, CEP 已提交, 韩国 DMF
作用机制
替扎尼定是一种中枢α2-肾上腺素能受体激动剂,其作用机制可能是通过增强运动神经元的突触前抑制来减轻痉挛。替扎尼定对多突触通路的作用最为显著。这些作用的总体效果被认为可以减少脊髓运动神经元的易化作用。
适应症
Zanaflex 是一种中枢 α2-肾上腺素能激动剂,适用于治疗痉挛。
Dr. Reddy's的专长
Dr. Reddy's总部位于印度海得拉巴,是全球领先的活性药物成分(API)供应商之一。 Dr. Reddy's的API业务是美国、欧洲、巴西、拉丁美洲、日本、中国、韩国和新兴市场的制药公司的首选合作伙伴。
Dr. Reddy's博士的API业务在过去30多年来在开发和制造复杂API(如类固醇,多肽,复杂长链分子和高效API(HPAPI /肿瘤药物))方面所建立的深厚技术优势中茁壮成长。 我们在知识产权和法规事务方面的实力可以帮助我们始终如一地达到并超越监管标准,从而为这一专业知识提供补充。 Dr. Reddy's博士 盐酸替扎尼定 API是研发,知识产权和监管方面广泛专业知识的结果。
帮助我们的客户率先进入市场的关键组成部分是响应式供应链。 我们通过确保所有设施都高效运行并达到最新的质量,安全和生产率标准来实现这一目标。 业务和工厂之间的强大互联可以快速响应动态的市场变化,从而避免短缺并满足需求的突然激增。
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
免责声明
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.